Your Article Summary
See Latest ArticlesDo PPIs and H2-blockers increase the risk of hip fractures
American Pharmacists Association, 06/25/09
Results from a large, population-based, retrospective analysis concluded that proton pump inhibitors (PPIs) and histamine-2 (H2)-receptor blockers are associated with an increased risk of hip fracture; this risk was increased with higher doses and longer duration of use.
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Newly Revised Prescribing Information For Azilect Reducing Medication And Food Restrictions
Teva Pharmaceutical Industries, 12/15/09
Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia
Current Medical Research and Opinion, 12/14/09
Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children
Pediatric Allergy and Immunology, 12/14/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability
Journal of Pharmacy and Pharmacology, 12/15/09
Novel TNF antagonists for the treatment of rheumatoid arthritis
Expert Opinion on Investigational Drugs, 12/15/09
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09